OTCM
JRSS
Market cap1mUSD
Oct 07, Last price
0.01USD
1D
0.00%
1Q
-23.91%
IPO
-97.60%
Name
JRsis Health Care Corp
Chart & performance
P/E
134.34
P/S
3.70
EPS
0.00
Div yield, %
—
Shrs. gr., 5y
35.87%
Rev. gr., 5y
-61.05%
Revenues
320k
-75.83%
Net income
9k
P
CFO
-136k
L-69.07%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
JRSIS Health Care Corporation develops and produces medical technology and equipment in the People's Republic of China. The company develops and markets a multi-faceted smart environment for the retail distribution of pharmaceutical products by pharmacies, hospitals, and online distributors. It offers JM-YF-2000 Automatic Medicine Dispenser, which provides intelligent prompts for high-speed facile human-computer interaction to yield prompt dispensing of medications and batch refilling in the user safety environment. The company was founded in 2018 and is based in Yongzhou, the People's Republic of China.
Key people
Lihua Sun
Chief Executive Officer, Director
Suya Li
Chief Operating Officer · since 2018
Yanhui Xing
Director
Junsheng Zhang
Chairman of the Board, President · since 2013
Yanming Zhang
Director · since 2018
Xuewei Zhang
Chief Financial Officer, Director
Guoqing Jin
Independent Director · since 2018
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||